Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry
(MedPage Today) -- Poison centers reported a sharp increase in calls related to accidental overdoses of the diabetes and weight-loss drug semaglutide (Ozempic, Wegovy). (CNN)
Some patients with diabetes are having a tougher time getting reimbursed... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 19, 2023 Category: Endocrinology Source Type: news
New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelves
(MedPage Today) -- The American Diabetes Association released its 2024 installment of the Standard of Care in Diabetes, featuring updates on screening, obesity drugs, new technology, and teplizumab (Tzield). (Diabetes Care)
Almost 40% of adults... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 12, 2023 Category: Endocrinology Source Type: news
Teens' High BMI Tied to Early Chronic Kidney Disease
(MedPage Today) -- High body mass index (BMI) at ages 16 to 20 was associated with chronic kidney disease (CKD) in early adulthood, a large cohort study showed.
Adjusted hazard ratios for CKD before age 45 ranged from 1.8 to 9.4 across BMI classes... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 11, 2023 Category: Endocrinology Source Type: news
Metformin Linked to Lower Odds of Developing AMD in Non-Diabetic Patients
(MedPage Today) -- Use of metformin was associated with lower odds of developing age-related macular degeneration (AMD) among patients without a diabetes diagnosis, offering more evidence of a possible role for the inexpensive drug in eye health... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 7, 2023 Category: Endocrinology Source Type: news
Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D
(MedPage Today) -- Pemvidutide (2.4 mg), an investigational GLP-1/glucagon dual receptor agonist, helped people with obesity achieve an average 15.6% weight loss after 48 weeks in the phase II MOMENTUM trial, developer Altimmune announced.
Meanwhile... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 4, 2023 Category: Endocrinology Source Type: news
Year in Review: Obesity
(MedPage Today) -- This year's headlines featured new FDA approvals, investigational drugs that scored success in major trials, new bariatric surgery benefits, and questions on the clinical utility of body mass index (BMI).
New Approvals, Indications... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 1, 2023 Category: Endocrinology Source Type: news
Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis
(MedPage Today) -- A real-world, preprint study in medRxiv found that people with overweight or obesity were up to three times more likely to lose significant weight with tirzepatide (Mounjaro) than with semaglutide (Ozempic), though the study... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 27, 2023 Category: Endocrinology Source Type: news
Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd
(MedPage Today) -- The FDA announced a voluntary recall of an over-the-counter glucose support supplement for the presence of metformin and glyburide.
Over the past two decades, the prevalence of diabetes and obesity, respectively, increased from... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 21, 2023 Category: Endocrinology Source Type: news
Infertility Linked With Small Autism Risk
(MedPage Today) -- Children of parents with infertility had a slightly higher rate of autism spectrum disorder, a population-based cohort study of over 1.3 million children found.
Compared with children born from unassisted conception, parents... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 20, 2023 Category: Endocrinology Source Type: news
Brolucizumab Noninferior to Aflibercept for Diabetic Macular Edema
(MedPage Today) -- Brolucizumab (Beovu) proved noninferior to aflibercept (Eylea) for visual outcomes among patients with diabetic macular edema (DME), the phase III KINGFISHER trial showed.
In over 500 patients with DME, the best-corrected visual... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 17, 2023 Category: Endocrinology Source Type: news
Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes
(MedPage Today) -- More than one in three adults have prediabetes, representing around 98 million Americans, but 81% of them don't know it, the CDC said as part of a national PSA to raise awareness.
The federal government's dietary guidelines... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 15, 2023 Category: Endocrinology Source Type: news
Diabetes Linked to Higher Colorectal Cancer Risk
(MedPage Today) -- Diagnosis of type 2 diabetes was associated with a higher risk for colorectal cancer (CRC) in a large, prospectively followed U.S. cohort of mostly Black adults with low socioeconomic status.
Among over 54,000 participants in... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 14, 2023 Category: Endocrinology Source Type: news
Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil?
(MedPage Today) -- Primary care patients with obesity were more likely to successfully lose weight through a behavioral weight management program if their physicians used an optimistic tone while discussing it as a treatment option. (Annals of... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 7, 2023 Category: Endocrinology Source Type: news
Gene Therapy Controls Diabetic Eye Disease for at Least a Year
(MedPage Today) -- SAN FRANCISCO -- A form of gene therapy stabilized or improved diabetic retinopathy (DR) for up to a year, particularly in patients with nonproliferative (NP) DR, a small clinical study showed.
Overall, about 40% of patients... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 6, 2023 Category: Endocrinology Source Type: news
Eye Drops Make Bid for Role in Diabetic Macular Edema
(MedPage Today) -- SAN FRANCISCO -- A noninvasive treatment for diabetic macular edema (DME) produced early evidence of efficacy in a study reported here.
Best corrected visual acuity (BCVA) improved by more than seven Early Treatment Diabetic... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 6, 2023 Category: Endocrinology Source Type: news
